Improved Postoperative Outcomes after Prehabilitation for Colorectal Cancer Surgery in Older Patients: An Emulated Target Trial Thea C. HeilEmiel G. G. VerdaasdonkRené J. F. Melis Colorectal Cancer Open access 05 October 2022 Pages: 244 - 254
ASO Author Reflections: Real-World Effectiveness of Prehabilitation Before Colorectal Cancer Surgery: The Value of an Emulated Target Trial Design Thea C. HeilEmiel G. G. VerdaasdonkRené J. F. Melis ASO Author Reflections Open access 17 October 2022 Pages: 255 - 256
ASO Visual Abstract: Improved Postoperative Outcomes After Prehabilitation for Colorectal Cancer Surgery in Older Patients: An Emulated Target Trial Thea C. HeilEmiel G. G. VerdaasdonkRené J. F. Melis ASO Visual Abstract 01 November 2022 Pages: 257 - 258
Circulating Tumor DNA, Imaging, and Carcinoembryonic Antigen: Comparison of Surveillance Strategies Among Patients Who Underwent Resection of Colorectal Cancer—A Systematic Review and Meta-analysis Zaiba Shafik DawoodLaura AlaimoTimothy M. Pawlik Colorectal Cancer 11 October 2022 Pages: 259 - 274
ASO Author Reflections: Assessing the Diagnostic Accuracy of Circulating Tumor DNA, Imaging, and Carcinoembryonic Antigen to Detect Recurrent Colon Cancer Zaiba Shafik DawoodZorays MoazzamTimothy M. Pawlik ASO Author Reflections 30 October 2022 Pages: 275 - 276
ASO Visual Abstract: Circulating Tumor DNA, Imaging, and Carcinoembryonic Antigen: Comparison of Surveillance Strategies in Patients Who Underwent Resection pf Colorectal Cancer: A Systematic Review and Meta-Analysis Zaiba Shafik DawoodLaura AlaimoTimothy M. Pawlik ASO Visual Abstract 01 November 2022 Pages: 277 - 277
Circulating Tumor DNA is Unreliable to Detect Somatic Gene Alterations in Gastrointestinal Peritoneal Carcinomatosis Brittany G. SullivanAngelina LoMaheswari Senthil Gastrointestinal Oncology Open access 18 August 2022 Pages: 278 - 284
ASO Author Reflections: Challenges of Circulating Tumor DNA in the Management of Gastrointestinal Peritoneal Carcinomatosis Brittany G. SullivanFarshid DayyaniMaheswari Senthil ASO Author Reflections Open access 13 September 2022 Pages: 285 - 286
ASO Visual Abstract: Circulating Tumor DNA is Unreliable to Detect Somatic Gene Alterations in Gastrointestinal Peritoneal Carcinomatosis Brittany G. SullivanAngelina LoMaheswari Senthil ASO Visual Abstract 08 October 2022 Pages: 287 - 288
Is Total Omentectomy Mandatory in T3 and T4a Gastric Cancer for Laparoscopic Distal Gastrectomy? Hayemin LeeDong Jin KimWook Kim Gastrointestinal Oncology 23 August 2022 Pages: 289 - 297
ASO Visual Abstract: Is Total Omentectomy Mandatory in T3 and T4a Gastric Cancer for Laparoscopic Distal Gastrectomy? Hayemin LeeDong Jin KimWook Kim ASO Visual Abstract 04 November 2022 Pages: 298 - 299
Regional Patterns of Hospital-Level Guideline Adherence in Gastric Cancer: An Analysis of the National Cancer Database Sarah R. KaslowLeena HaniCamilo Correa-Gallego Gastrointestinal Oncology 19 September 2022 Pages: 300 - 308
ASO Author Reflections: Location, Location, Location? Drivers of Variation in Guideline Adherence in the Treatment of Gastric Cancer Sarah R. KaslowCamilo Correa-Gallego ASO Author Reflections 27 September 2022 Pages: 309 - 310
ASO Visual Abstract: Regional Patterns of Hospital-Level Guideline Adherence in Gastric Cancer—An Analysis of the National Cancer Database Sarah R. KaslowLeena HaniCamilo Correa-Gallego ASO Visual Abstract 16 October 2022 Pages: 311 - 312
Is Palliative Gastrojejunostomy for Malignant Gastric Outlet Obstruction an Optimal Choice for Very Elderly Patients? A Report from a Long-Lived Country Siyuan YaoRyosuke KitaTakehisa Harada Gastrointestinal Oncology 28 September 2022 Pages: 313 - 321
ASO Author Reflections: Palliative Surgery for Very Elderly Cancer Patients Does Not Guarantee Surgical Safety Siyuan YaoRyosuke Kita ASO Author Reflections 25 September 2022 Pages: 322 - 322
ASO Visual Abstract: Is Palliative Gastrojejunostomy for Malignant Gastric Outlet Obstruction an Optimal Choice for Very Elderly Patients? A Report from a Long-Lived Country Siyuan YaoRyosuke KitaTakehisa Harada ASO Visual Abstract 22 October 2022 Pages: 323 - 324
Intra-operative Radiation Therapy for Colorectal or Anal Cancer at Risk for Margin-Positive Resection: Initial Results of a Single-Institution Registry Muzamil ArshadHania Al-HallaqStanley L. Liauw Gastrointestinal Oncology 18 October 2022 Pages: 325 - 332
ASO Visual Abstract: Intraoperative Radiation Therapy for Colorectal or Anal Cancer at Risk for Margin-Positive Resection: Initial Results of a Single-Institution Registry Muzamil ArshadHania Al-HallaqStanley L. Liauw ASO Visual Abstract 12 October 2022 Pages: 333 - 334
Disparities in Care Access to Liver-Directed Therapy Among Medicare Beneficiaries with Colorectal Cancer Liver Metastasis Christopher T. AquinaZachary J. BrownAlex C. Kim Hepatobiliary Tumors 23 September 2022 Pages: 335 - 344
ASO Visual Abstract: Disparities in␣Care Access to␣Liver-Directed Therapy Among Medicare Beneficiaries with␣Colorectal Cancer Liver Metastasis Christopher T. AquinaZachary J. BrownAlex C. Kim ASO Visual Abstract 11 October 2022 Pages: 345 - 345
Association of Concurrent Metabolic Syndrome with Long-term Oncological Prognosis Following Liver Resection for Hepatocellular Carcinoma Among Patients with Chronic Hepatitis B Virus Infection: A Multicenter Study of 1753 Patients Ming-Da WangShi-Chuan TangTian Yang Hepatobiliary Tumors 16 September 2022 Pages: 346 - 358
ASO Author Reflections: Effect of Preoperative Metabolic Syndrome for Patients with Hepatocellular Carcinoma Ming-Da WangFeng ShenTian Yang ASO Author Reflections 19 September 2022 Pages: 359 - 360
ASO Visual Abstract: Association of Concurrent Metabolic Syndrome with Long-term Oncological Prognosis Following Liver Resection for Hepatocellular Carcinoma Among Patients with Chronic Hepatitis B Virus Infection—A Multicenter Study of 1753 Patients Ming-Da WangShi-Chuan TangTian Yang ASO Visual Abstract 02 October 2022 Pages: 361 - 362
A Practical Risk Classification of Early Recurrence in Hepatocellular Carcinoma Patients with Microvascular invasion after Hepatectomy: A Decision Tree Analysis Long-Hai FengYu-Yao ZhuLu Wang Hepatobiliary Tumors 23 September 2022 Pages: 363 - 372
ASO Author Reflections: Early Recurrence in Hepatocellular Carcinoma Patients with Microvascular Invasion After Hepatectomy Long-Hai FengYu-Yao ZhuLu Wang ASO Author Reflections 19 October 2022 Pages: 373 - 374
Laparoscopic Anatomical Extended Right Posterior Sectionectomy Using Virtual Liver Segment Projection Navigation and Indocyanine Green Fluorescence Imaging Xiaojun ZengWen ZhuChihua Fang Hepatobiliary Tumors 08 October 2022 Pages: 375 - 376
ASO Author Reflections: Anatomical Extended Right Posterior Sectionectomy: A New Surgical Strategy for Right Liver Tumor in the Digital Intelligent Liver Surgery Era Xiaojun ZengJian YangChihua Fang ASO Author Reflections 03 October 2022 Pages: 377 - 378
ASO Visual Abstract: Laparoscopic Anatomical Extended Right Posterior Sectionectomy Using Virtual Liver Segment Projection Navigation and Indocyanine Green Fluorescence Imaging Xiaojun ZengWen ZhuChihua Fang ASO Visual Abstract 02 October 2022 Pages: 379 - 380
Laparoscopic Medial-to-Lateral Approach for the Resection of Hepatocellular Carcinoma Located at the Spiegel Lobe of the Liver Hidetoshi GonMasahiro KidoTakumi Fukumoto Hepatobiliary Tumors 25 October 2022 Pages: 381 - 382
Safe Laparoscopic Resection of Hepatocellular Carcinoma in the Spiegel Lobe of the Liver Using a Medial-to-Lateral Approach Hidetoshi GonMasahiro KidoTakumi Fukumoto ASO Author Reflections 27 October 2022 Pages: 383 - 383
Switching Perfusion Agents for Repeat Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy: Surgical Dogma or Evidence-Based Practice? Christopher W. MangieriCristian D. ValenzuelaEdward A. Levine Peritoneal Surface Malignancy 15 August 2022 Pages: 384 - 391
ASO Author Reflections: Evaluating HIPEC Switch for Repeat CRS–HIPEC, Time to End a Common Practice? Christopher W. MangieriEdward A. Levine ASO Author Reflections 06 September 2022 Pages: 392 - 393
ASO Visual Abstract: Switching Perfusion Agents for Repeat Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy, Surgical Dogma or Evidence-Based Practice? Christopher W. MangieriCristian D. ValenzuelaEdward A. Levine ASO Visual Abstract 04 September 2022 Pages: 394 - 394
Cytoreduction with Hyperthermic Intraperitoneal Chemoperfusion for Pancreatic Cancer with Low-Volume Peritoneal Metastasis: Results from a Prospective Pilot Study Travis E. GrotzJennifer A. YonkusMark J. Truty Peritoneal Surface Malignancy 16 August 2022 Pages: 395 - 403
Relapse of Pseudomyxoma Peritonei After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: Pattern of Failure, Clinical Management and Outcomes Dario BarattiShigeki KusamuraMarcello Deraco Peritoneal Surface Malignancy 12 September 2022 Pages: 404 - 414
ASO Author Reflections: Management of Recurrent Pseudomyxoma Peritonei After Cytoreductive Surgery and HIPEC D. BarattiM. Deraco ASO Author Reflections 09 September 2022 Pages: 415 - 416
Insurance Authorization Barriers in Patients Undergoing Cytoreductive Surgery and HIPEC Cecilia T. OngAnkit DhimanOliver S. Eng Peritoneal Surface Malignancy 16 September 2022 Pages: 417 - 422
ASO Author Reflections: The Current Insurance Authorization Process and Future Directions for Patients Undergoing Cytoreductive Surgery and HIPEC Cecilia T. OngOliver S. Eng ASO Author Reflections 02 October 2022 Pages: 423 - 424
ASO Visual Abstract: Insurance Authorization Barriers in Patients Undergoing Cytoreductive Surgery and HIPEC Cecilia T. OngAnkit DhimanOliver S. Eng ASO Visual Abstract 07 September 2022 Pages: 425 - 425
Combined Prophylactic Hyperthermic Intraperitoneal Chemotherapy and Intraoperative Radiotherapy for Localized Gastroesophageal Junction and Gastric Cancer: A Comparative Nonrandomized Study Shouki BazarbashiAhmed BadranMahmoud A. Elshenawy Peritoneal Surface Malignancy 30 August 2022 Pages: 426 - 432
ASO Author Reflections: Intraoperative Anticancer Therapy for Resected Gastric Cancer Shouki Bazarbashi ASO Author Reflections 24 September 2022 Pages: 433 - 434
ASO Visual Abstract: Combined Prophylactic Hyperthermic Intraperitoneal Chemotherapy and Intraoperative Radiotherapy for Localized Gastroesophageal Junction and Gastric Cancer—A Comparative Nonrandomized Study Shouki BazarbashiAhmed BadranMahmoud A. Elshenawy ASO Visual Abstract 04 September 2022 Pages: 435 - 436
Postoperative Respiratory Failure Following Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy is Associated with Volume of Intraoperative Crystalloid Administration and Worse Survival Eric PletcherDa Eun ChaBenjamin Golas Peritoneal Surface Malignancy 30 July 2022 Pages: 437 - 444
ASO Visual Abstract: Postoperative Respiratory Failure Following Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy is Associated with Volume of Intraoperative Crystalloid Administration and Worse Survival Eric PletcherDa Eun ChaBenjamin Golas ASO Visual Abstract 18 October 2022 Pages: 445 - 446
Functional Outcomes Following Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: A Prospective Cohort Study Preet G. S. MakkerCherry E. KohDaniel Steffens Peritoneal Surface Malignancy Open access 28 October 2022 Pages: 447 - 458
ASO Author Reflections: Pre-operative Function Status Predicts Post-operative Outcomes in Patients Undergoing Cytoreductive Surgery and Hyperthermic Intra-peritoneal Chemotherapy Preet G. S. MakkerCherry KohDaniel Steffens ASO Author Reflections 28 October 2022 Pages: 459 - 460
ASO Visual Abstract: Functional Outcomes of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy—A Prospective Cohort Study Preet G. S. MakkerCherry E. KohDaniel Steffens ASO Visual Abstract 14 November 2022 Pages: 461 - 461
Imaging of the Lymphatic Vessels for Surgical Planning: A Systematic Review Saskia van HeumenJonas J. M. RiksenDalibor Vasilic Reconstructive Oncology Open access 28 September 2022 Pages: 462 - 479
Re-excision After Unplanned Excision of Soft Tissue Sarcoma is Associated with High Morbidity and Limited Pathologic Identification of Residual Disease Raymond S. TraweekAllison N. MartinChristopher P. Scally Sarcoma 09 September 2022 Pages: 480 - 489